Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Hawkinsinuria is an inborn error of tyrosine metabolism characterized by failure to thrive, persistent metabolic acidosis, fine and sparse hair, and excretion of the unusual cyclic amino acid metabolite, hawkinsin ((2-l-cystein-S-yl, 4-dihydroxycyclohex-5-en-1-yl)acetic acid), in the urine.
Features include always present findings: Hypertyrosinemia, 4-Hydroxyphenylpyruvic aciduria, Hawkinsinuria, and 4-hydroxyphenylacetic aciduria; and common findings: Microcephaly, Mild intellectual disability, Sparse hair, and Failure to thrive and others. 11 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Head and neck | 1 | Microcephaly |
HPD encodes 4-hydroxyphenylpyruvate dioxygenase (393 aa). Catalyzes the conversion of 4-hydroxyphenylpyruvic acid to homogentisic acid, one of the steps in tyrosine catabolism Highest expression in Liver (1,002 TPM) and Kidney Cortex (168.7 TPM).
Hawkinsinuria has limited evidence linking it to mutations in the HPD gene on chromosome 12.
The HPD protein participates in HPD dioxygenates HPP, HPDL dioxygenates HPPA, and Unknown enzyme hydrogenates HPP pathways.
HPD is classified as a druggable target (Druggable Genome and Enzyme categories) with score 52.2.
Genetic testing for HPD is available. Testing is considered research-grade for diagnosis.
Phenotype severity distribution: 4 always present features, 6 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for hawkinsinuria.
5 publications have been identified in PubMed for hawkinsinuria. Research spans Basic Science / Preclinical (80%) and Case Report / Case Series (20%).
Sun T (2026). [PMID: 41725899](https://pubmed.ncbi.nlm.nih.gov/41725899/). *Synth Syst Biotechnol*. [Basic Science / Preclinical]
Lindlar NSW (2026). [PMID: 41806056](https://pubmed.ncbi.nlm.nih.gov/41806056/). *J Biol Inorg Chem*. [Basic Science / Preclinical]
Huang CW (2026). [PMID: 42140431](https://pubmed.ncbi.nlm.nih.gov/42140431/). *J Biol Chem*. [Basic Science / Preclinical]
Bassett J (2025). [PMID: 40789710](https://pubmed.ncbi.nlm.nih.gov/40789710/). *BMJ Case Rep*. [Case Report / Case Series]
Trezza A (2024). [PMID: 38927403](https://pubmed.ncbi.nlm.nih.gov/38927403/). *Biomedicines*. [Basic Science / Preclinical]
Data assembled from 7 of 12 sources · Last updated Sep 18, 2026, 8:51 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Brain and nerves |
1 |
Mild intellectual disability |
Growth and development | 1 | Failure to thrive |
Metabolism | 1 | Metabolic acidosis |